Apposite Capital acquires majority stake in CrestOptics

November 11, 2021 - CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, has sold a majority stake to Apposite Capital LLP, a private equity investor specializing in the healthcare sector. As part of the transaction, Xyence divested a portion of its shares and will remain with a 25% stake in the company to support the company's commercial expansion into new markets and further development of innovative cellular imaging products.